Rho, a contract research organization (CRO) providing clinical research services in both the commercial and federal market, has been awarded the renewal of their existing federal contract with the National Institute of Dental and Craniofacial Research (NIDCR). The NC-based CRO will provide clinical research operations and management support (CROMS) to the NIDCR and to NIDCR funded clinical research studies from study preparation and initiation through study completion and close-out.
The $4.2 million one year contract includes four one-year options with a total estimated ceiling of $21.9 million.
“We are excited to support NIDCR’s research divisions and continue building the infrastructure for groundbreaking studies of oral, dental and craniofacial diseases and disorders,” said Laura Helms Reece, Dr. P.H., chief executive officer for Rho. “Rho’s expertise and resources will help assure top-notch study design and execution, data management, statistical analysis, and regulatory compliance.”
Date: October 21, 2014
Source: Rho
Filed Under: Drug Discovery
